The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus.

Autor Duhaylongsod, F G, Gottfried, M R, Iglehart, J D, Vaughn, A L, Wolfe, W G
Vydáno 1995

Early results with combined modality therapy for carcinoma of the esophagus.

Autor Wolfe, W G, Burton, G V, Seigler, H F, Crocker, I R, Vaughn, A L
Vydáno 1987